Startseite Enhancement of chondrogenic differentiation in ATDC5 cells using GFOGER-modified peptide nanofiber scaffold
Artikel Open Access

Enhancement of chondrogenic differentiation in ATDC5 cells using GFOGER-modified peptide nanofiber scaffold

Dieses Erratum berichtigt die Onlineversion des folgenden Artikels: https://doi.org/10.1515/tjb-2023-0115
  • Seher Yaylaci ORCID logo EMAIL logo
Veröffentlicht/Copyright: 22. August 2025

Corrigendum to: Yaylacı S. Enhancement of chondrogenic differentiation in ATDC5 cells using GFOGER-modified peptide nanofiber scaffold. Turk J Biochem 2023;48:659–67. https://doi.org/10.1515/tjb-2023-0115.

The authors regret that Figure 1E and Figure 1F in the originally published article did not reflect the exact experimental data generated in this study due to an oversight during figure compilation.

The correct versions of Figure 1E and Figure 1F, derived directly from the experimental results of this study, are presented below to ensure full scientific accuracy. These corrections do not affect the results or conclusions of the study.

Figure 1E (Corrected): 
LC chromatogram of K-PA.
Figure 1E (Corrected):

LC chromatogram of K-PA.

Figure 1F (Corrected): 
Scanning electron microscope micrograph of indicated nanofibers.
Figure 1F (Corrected):

Scanning electron microscope micrograph of indicated nanofibers.

Figure 1: 
(A) Chemical structures of PA molecules. MS spectrum of (B) GFOGER-PA and (C) K-PA. LC chromatogram of (D) GFOGER-PA and (E) K-PA. (F) Scanning electron microscope micrograph of indicated nanofibers.
Figure 1:

(A) Chemical structures of PA molecules. MS spectrum of (B) GFOGER-PA and (C) K-PA. LC chromatogram of (D) GFOGER-PA and (E) K-PA. (F) Scanning electron microscope micrograph of indicated nanofibers.


Corresponding author: Seher Yaylaci, Faculty of Medicine, Lokman Hekim University, Ankara, Türkiye, E-mail:

Published Online: 2025-08-22

© 2025 the author(s), published by De Gruyter, Berlin/Boston

This work is licensed under the Creative Commons Attribution 4.0 International License.

Artikel in diesem Heft

  1. Frontmatter
  2. Review Article
  3. Systematic review and meta-analysis of dysregulated miRNAs in patients with severe pneumonia
  4. Research Articles
  5. The clinical significance of miR-590-3p in acute myeloid leukemia and potential regulatory mechanism based on bioinformatic prediction
  6. Clinical value of lncRNA CARMN expression in threatened abortion and its effect on cell function of HTR-8/SVneo
  7. Serum aberrant expression of LINC00963 and its diagnostic value in carotid artery stenosis
  8. Comparison of various fragmentation methods of alpha-synuclein fibrils for establishing a Parkinson’s disease-like model in cell culture
  9. Notoginsenoside R1 inhibits Ang II-induced VSMCs migration by upregulating Sirt1 expression
  10. Effects of dexmedetomidine on cardiac electrical activity and ion currents: an experimental animal study
  11. Serum adropin, clusterin, hemokinin-1, and kisspeptin levels in patients with migraine
  12. Investigation of the relationship between vascular events and copeptin levels in hospitalized COVID-19 patients
  13. Statistical insights into ethanol testing: demographic variations and laboratory performance – a core laboratory experience
  14. Establishing continuous reference intervals for liver function analytes using fractional polynomial regression
  15. Comparison of age-related changes in glomerular filtration rate: creatinine-based formulae vs. radioisotopic method
  16. The prognostic and clinical significance of hemogram parameters: a single-center retrospective analysis
  17. Relationship between subarachnoid haemorrhage and vasospasm, platelet count, mean platelet volume, platelet distribution width
  18. Effect of blood collection tube variability on biochemistry test reliability: focus on possible contamination and other discrepancies
  19. Patient-based quality control: a complementary tool for external quality assessment in analytical performance evaluation
  20. Clinicians’ perspectives and practices on critical outcomes and their expectations from the laboratory
  21. Corrigendum
  22. Enhancement of chondrogenic differentiation in ATDC5 cells using GFOGER-modified peptide nanofiber scaffold
Heruntergeladen am 21.9.2025 von https://www.degruyterbrill.com/document/doi/10.1515/tjb-2025-0179/html
Button zum nach oben scrollen